The health and economic burden of musculoskeletal disorders in Belgium from 2013 to 2018.
Absenteeism costs
Disability-adjusted life years
Healthcare costs
Musculoskeletal disorders
Journal
Population health metrics
ISSN: 1478-7954
Titre abrégé: Popul Health Metr
Pays: England
ID NLM: 101178411
Informations de publication
Date de publication:
21 04 2023
21 04 2023
Historique:
received:
13
09
2022
accepted:
13
03
2023
medline:
25
4
2023
pubmed:
22
4
2023
entrez:
21
04
2023
Statut:
epublish
Résumé
Low back pain (LBP), neck pain (NKP), osteoarthritis (OST) and rheumatoid arthritis (RHE) are among the musculoskeletal (MSK) disorders causing the greatest disability in terms of Years Lived with Disability. The current study aims to analyze the health and economic impact of these MSK disorders in Belgium, providing a summary of morbidity and mortality outcomes from 2013 to 2018, as well as direct and indirect costs from 2013 to 2017. The health burden of LBP, NKP, OST and RHE in Belgium from 2013 to 2018 was summarized in terms of prevalence and disability-adjusted life years (DALY) using data from the Belgian health interview surveys (BHIS), the INTEGO database (Belgian registration network for general practitioners) and the Global Burden of Diseases study 2019. The economic burden included estimates of direct medical costs and indirect costs, measured by cost of work absenteeism. For this purpose, data of the respondents to the BHIS-2013 were linked with the national health insurance data (intermutualistic agency [IMA] database) 2013-2017. In 2018, 2.5 million Belgians were affected by at least one MSK disorder. OST represented the disorder with the highest number of cases for both men and women, followed by LBP. In the same year, MSK disorders contributed to a total of 180,746 DALYs for female and 116,063 DALYs for men. LBP appeared to be the largest contributor to the health burden of MSK. Having at least one MSK disorder costed on average 3 billion € in medical expenses and 2 billion € in indirect costs per year, with LBP being the most costly. MSK disorders represent a major health and economic burden in Belgium. As their burden will probably continue to increase in the future, acting on the risk factors associated to these disorders is crucial to mitigate both the health and economic burden.
Identifiants
pubmed: 37085871
doi: 10.1186/s12963-023-00303-z
pii: 10.1186/s12963-023-00303-z
pmc: PMC10122398
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4Informations de copyright
© 2023. The Author(s).
Références
Soz Praventivmed. 2003;48(4):269-71
pubmed: 12971115
Clin J Pain. 2006 Oct;22(8):717-24
pubmed: 16988568
Bull World Health Organ. 2018 May 1;96(5):366-368
pubmed: 29875522
Ann Rheum Dis. 2020 Jun;79(6):819-828
pubmed: 32398285
Occup Environ Med. 2016 Jan;73(1):62-70
pubmed: 26552695
Eur Spine J. 2018 Nov;27(11):2875-2881
pubmed: 30155730
Arch Public Health. 2016 Aug 22;74:37
pubmed: 27551405
Gerontologist. 2016 Apr;56 Suppl 2:S243-55
pubmed: 26994264
Cent Eur J Public Health. 2020 Oct;28 Suppl:S06-S11
pubmed: 33069174
Ann Rheum Dis. 2010 Jan;69 Suppl 1:i89-91
pubmed: 19995754
Arch Public Health. 2013 Sep 18;71(1):24
pubmed: 24047278
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
PLoS One. 2019 May 29;14(5):e0216526
pubmed: 31141520
Lancet. 2019 Apr 27;393(10182):1745-1759
pubmed: 31034380
Epidemiol Methods. 2014 Jan;2(1):95-115
pubmed: 25580377
JAMA Intern Med. 2016 Feb;176(2):199-208
pubmed: 26752509
BMC Med Res Methodol. 2020 May 6;20(1):100
pubmed: 32375653
Nat Rev Rheumatol. 2016 Feb;12(2):92-101
pubmed: 26439406
Fam Pract. 2005 Aug;22(4):442-7
pubmed: 15964863
Am J Epidemiol. 2011 Apr 1;173(7):731-8
pubmed: 21415029
BMJ. 2001 May 5;322(7294):1079-80
pubmed: 11337425
Med J Aust. 2015 Sep 21;203(6):260.e1-6
pubmed: 26377293